KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant

BMC Med Genet. 2015 Oct 31:16:101. doi: 10.1186/s12881-015-0247-1.

Abstract

Background: Linear nevus sebaceous syndrome (LNSS) is a multisystem disorder that includes nevus sebaceous and central nervous system, ocular and skeletal anomalies. We report the first case of a KRAS G12D mosaic mutation in a patient diagnosed with LNSS.

Case presentation: A 3-month-old female with a clinical diagnosis of LNSS presented with intermittent epilepsy. Her mother carefully collected a skin lesion sample from scratched-off scurf obtained from the patient's nails. DNA was extracted, and long-range PCR was performed to amplify the KRAS gene, which was then analyzed by next-generation sequencing. The results revealed the presence of a low-level heterozygous mutation in the KRAS gene (c.35C>T; p.G12D, 5 %).

Conclusions: These findings suggest that the KRAS somatic mosaic mutation in this patient may have caused her skin and eye lesions and epilepsy. With this correct diagnosis, the infant can be effectively treated.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Epilepsy / genetics
  • Exons
  • Eye / pathology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Mutation
  • Nevus, Sebaceous of Jadassohn / genetics*
  • Nevus, Sebaceous of Jadassohn / pathology
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Skin / pathology

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)